U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Stage IV Splenic Marginal Zone Lymphoma

MedGen UID:
208981
•Concept ID:
C0856027
•
Neoplastic Process

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVStage IV Splenic Marginal Zone Lymphoma

Professional guidelines

PubMed

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B
Clin Lymphoma 2002 Jun;3(1):41-7. doi: 10.3816/clm.2002.n.010. PMID: 12141954

Recent clinical studies

Etiology

Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB, Shen DH, Yang SM, Fang XZ
Pathol Res Pract 2018 Dec;214(12):1952-1958. Epub 2018 Jul 27 doi: 10.1016/j.prp.2018.07.021. PMID: 30087035
Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Xing KH, Kahlon A, Skinnider BF, Connors JM, Gascoyne RD, Sehn LH, Savage KJ, Slack GW, Shenkier TN, Klasa R, Gerrie AS, Villa D
Br J Haematol 2015 May;169(4):520-7. Epub 2015 Apr 8 doi: 10.1111/bjh.13320. PMID: 25854936
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
Conconi A, Raderer M, Franceschetti S, Devizzi L, Ferreri AJ, Magagnoli M, Arcaini L, Zinzani PL, Martinelli G, Vitolo U, Kiesewetter B, Porro E, Stathis A, Gaidano G, Cavalli F, Zucca E
Br J Haematol 2014 Jul;166(1):69-76. Epub 2014 Mar 27 doi: 10.1111/bjh.12845. PMID: 24673512
Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients.
Chacón JI, Mollejo M, Muñoz E, Algara P, Mateo M, Lopez L, Andrade J, Carbonero IG, Martínez B, Piris MA, Cruz MA
Blood 2002 Sep 1;100(5):1648-54. PMID: 12176884
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B
Clin Lymphoma 2002 Jun;3(1):41-7. doi: 10.3816/clm.2002.n.010. PMID: 12141954

Diagnosis

Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
Lei Y, Huang Q, Li X, Zheng X, Liu M
Medicine (Baltimore) 2022 Jan 21;101(3):e28539. doi: 10.1097/MD.0000000000028539. PMID: 35060511Free PMC Article
Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB, Shen DH, Yang SM, Fang XZ
Pathol Res Pract 2018 Dec;214(12):1952-1958. Epub 2018 Jul 27 doi: 10.1016/j.prp.2018.07.021. PMID: 30087035
Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Xing KH, Kahlon A, Skinnider BF, Connors JM, Gascoyne RD, Sehn LH, Savage KJ, Slack GW, Shenkier TN, Klasa R, Gerrie AS, Villa D
Br J Haematol 2015 May;169(4):520-7. Epub 2015 Apr 8 doi: 10.1111/bjh.13320. PMID: 25854936
Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients.
Chacón JI, Mollejo M, Muñoz E, Algara P, Mateo M, Lopez L, Andrade J, Carbonero IG, Martínez B, Piris MA, Cruz MA
Blood 2002 Sep 1;100(5):1648-54. PMID: 12176884
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B
Clin Lymphoma 2002 Jun;3(1):41-7. doi: 10.3816/clm.2002.n.010. PMID: 12141954

Therapy

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
Rosenthal A, Dueck AC, Ansell S, Gano K, Conley C, Nowakowski GS, Camoriano J, Leis JF, Mikhael JR, Keith Stewart A, Inwards D, Dingli D, Kumar S, Noel P, Gertz M, Porrata L, Russell S, Colgan J, Fonseca R, Habermann TM, Kapoor P, Buadi F, Leung N, Tiedemann R, Witzig TE, Reeder C
Am J Hematol 2017 May;92(5):467-472. Epub 2017 Mar 22 doi: 10.1002/ajh.24693. PMID: 28230270
Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Xing KH, Kahlon A, Skinnider BF, Connors JM, Gascoyne RD, Sehn LH, Savage KJ, Slack GW, Shenkier TN, Klasa R, Gerrie AS, Villa D
Br J Haematol 2015 May;169(4):520-7. Epub 2015 Apr 8 doi: 10.1111/bjh.13320. PMID: 25854936
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
Conconi A, Raderer M, Franceschetti S, Devizzi L, Ferreri AJ, Magagnoli M, Arcaini L, Zinzani PL, Martinelli G, Vitolo U, Kiesewetter B, Porro E, Stathis A, Gaidano G, Cavalli F, Zucca E
Br J Haematol 2014 Jul;166(1):69-76. Epub 2014 Mar 27 doi: 10.1111/bjh.12845. PMID: 24673512
Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L, Paulli M, Boveri E, Vallisa D, Bernuzzi P, Orlandi E, Incardona P, Brusamolino E, Passamonti F, Burcheri S, Schena C, Pascutto C, Cavanna L, Magrini U, Lazzarino M
Cancer 2004 Jan 1;100(1):107-15. doi: 10.1002/cncr.11893. PMID: 14692030
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B
Clin Lymphoma 2002 Jun;3(1):41-7. doi: 10.3816/clm.2002.n.010. PMID: 12141954

Prognosis

Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
Lei Y, Huang Q, Li X, Zheng X, Liu M
Medicine (Baltimore) 2022 Jan 21;101(3):e28539. doi: 10.1097/MD.0000000000028539. PMID: 35060511Free PMC Article
Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB, Shen DH, Yang SM, Fang XZ
Pathol Res Pract 2018 Dec;214(12):1952-1958. Epub 2018 Jul 27 doi: 10.1016/j.prp.2018.07.021. PMID: 30087035
Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Xing KH, Kahlon A, Skinnider BF, Connors JM, Gascoyne RD, Sehn LH, Savage KJ, Slack GW, Shenkier TN, Klasa R, Gerrie AS, Villa D
Br J Haematol 2015 May;169(4):520-7. Epub 2015 Apr 8 doi: 10.1111/bjh.13320. PMID: 25854936
Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients.
Chacón JI, Mollejo M, Muñoz E, Algara P, Mateo M, Lopez L, Andrade J, Carbonero IG, Martínez B, Piris MA, Cruz MA
Blood 2002 Sep 1;100(5):1648-54. PMID: 12176884
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B
Clin Lymphoma 2002 Jun;3(1):41-7. doi: 10.3816/clm.2002.n.010. PMID: 12141954

Clinical prediction guides

Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
Lei Y, Huang Q, Li X, Zheng X, Liu M
Medicine (Baltimore) 2022 Jan 21;101(3):e28539. doi: 10.1097/MD.0000000000028539. PMID: 35060511Free PMC Article
Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Xing KH, Kahlon A, Skinnider BF, Connors JM, Gascoyne RD, Sehn LH, Savage KJ, Slack GW, Shenkier TN, Klasa R, Gerrie AS, Villa D
Br J Haematol 2015 May;169(4):520-7. Epub 2015 Apr 8 doi: 10.1111/bjh.13320. PMID: 25854936
A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases.
Traverse-Glehen A, Felman P, Callet-Bauchu E, Gazzo S, Baseggio L, Bryon PA, Thieblemont C, Coiffier B, Salles G, Berger F
Histopathology 2006 Jan;48(2):162-73. doi: 10.1111/j.1365-2559.2005.02309.x. PMID: 16405665
Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients.
Chacón JI, Mollejo M, Muñoz E, Algara P, Mateo M, Lopez L, Andrade J, Carbonero IG, Martínez B, Piris MA, Cruz MA
Blood 2002 Sep 1;100(5):1648-54. PMID: 12176884
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.
Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, Arcache J, Callet-Bauchu E, Salles G, Coiffier B
Clin Lymphoma 2002 Jun;3(1):41-7. doi: 10.3816/clm.2002.n.010. PMID: 12141954

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...